Riskpilot← Back to searchSign inGet full accessDigiMedIQ Sweden AB
ABActiveOrg 5593356305Dirkvägen 8Medical specialists activities · NACE 8622Est. 20211 employees
Revenue 2025
SEK 218K
-6% vs 2024
EBITDA margin
-94.4%
-303% vs 2024
Equity ratio
71.6%
Financial strength
Net profit 2025
SEK -201K
-342% vs 2024
| Revenue | SEK 218K | -6% |
| EBITDA | SEK -206K | -303% |
| Net profit | SEK -201K | -342% |
| Total assets | SEK 129K | -8% |
| Equity | SEK 92K | -25% |
| Employees | 1 | — |
Legal name
DigiMedIQ Sweden AB
Org number
5593356305
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 september 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk, radiologisk och teknisk konsultverksamhet, men kan också bedriva konstnärligt skapande inom företrädesvis bild, illustration, fotografi, litteratur. Företaget kan även bedriva utbildning, studiehjälp, handel med och förvaltning av värdepapper samt fast egendom, ävensom idka därmed förenlig verksamhet.
Address
Dirkvägen 8
Email
inbox@digimediq.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 248 | 261 | 232 | 218 |
| Staff expenses | −10 | −9 | −20 | −204 |
| EBITDA | 117 | 129 | 101 | −206 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 117 | 129 | 101 | −206 |
| Net financials | — | 0 | 3 | 5 |
| Profit before tax | 117 | 129 | 105 | −201 |
| Tax | −24 | −27 | −22 | — |
| Net profit | 93 | 102 | 83 | −201 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 164 | 194 | 140 | 129 |
| Equity | 148 | 190 | 123 | 92 |
| Long-term debt | — | — | — | — |
| Short-term debt | 16 | 3 | 17 | 37 |
| Total debt | 16 | 3 | 17 | 37 |
EBITDA margin
-94.4%
This company
15.8%
Market median
-697% vs market
20222025
Equity ratio
71.6%
This company
38.2%
Market median
+87% vs market
20222025
Return on equity
-218.3%
This company
18.4%
Market median
-1286% vs market
20222025
Net profit margin
-92.3%
This company
8.1%
Market median
-1240% vs market
20222025
Asset turnover
1.69×
This company
1.12×
Market median
+51% vs market
20222025
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-17 – 2022-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DigiMedIQ Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Anders Christian Kercsik | Chief Executive Officer | 0 companies |
| Imre Kercsik | Deputy Board Member | 0 companies |
| Agnes Linnea Abrahamsson | Deputy Board Member | 0 companies |